These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 17532008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level.
    Xiao HB, Jun-Fang, Lu XY, Chen XJ, Chao-Tan, Sun ZL.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):213-22. PubMed ID: 19549512
    [Abstract] [Full Text] [Related]

  • 5. Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice.
    Carnicer R, Navarro MA, Arbonés-Mainar JM, Acín S, Guzmán MA, Surra JC, Arnal C, de Las Heras M, Blanco-Vaca F, Osada J.
    Life Sci; 2007 Jan 23; 80(7):638-43. PubMed ID: 17118406
    [Abstract] [Full Text] [Related]

  • 6. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
    Desai A, Zhao Y, Warren JS.
    Cardiovasc Pathol; 2008 Jan 23; 17(4):233-40. PubMed ID: 18402814
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb 23; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC.
    Arterioscler Thromb Vasc Biol; 2006 Nov 23; 26(11):2552-9. PubMed ID: 16946130
    [Abstract] [Full Text] [Related]

  • 13. Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.
    Okabe TA, Shimada K, Hattori M, Murayama T, Yokode M, Kita T, Kishimoto C.
    Cardiovasc Res; 2007 Jun 01; 74(3):537-45. PubMed ID: 17374527
    [Abstract] [Full Text] [Related]

  • 14. Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice.
    Buus NH, Hansson NC, Rodriguez-Rodriguez R, Stankevicius E, Andersen MR, Simonsen U.
    Eur J Pharmacol; 2011 Nov 30; 670(2-3):519-26. PubMed ID: 21958874
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS, Panek RL, Mueller SB, Hanselman JC, Rosebury WS, Robertson AW, Kindt EK, Homan R, Karathanasis SK, Rekhter MD.
    Circulation; 2004 Nov 30; 110(22):3465-71. PubMed ID: 15545514
    [Abstract] [Full Text] [Related]

  • 17. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
    Godschalk RW, Albrecht C, Curfs DM, Schins RP, Bartsch H, van Schooten FJ, Nair J.
    Mutat Res; 2007 Aug 01; 621(1-2):87-94. PubMed ID: 17418875
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.